Tzamal Medical Group

What Tzamal Medical Group does

Tzamal Medical Group is a privately held, family-owned healthcare distribution platform headquartered in Petach Tikva, Israel, founded in 1972 by Joshua [Shuki] Katz. The group operates three wholly owned subsidiaries: Tzamal Bio-Pharma, which sources, imports, and distributes ethical and generic pharmaceuticals (including oncology, haemato-oncology, bone-marrow transplantation, cardiology, anti-infective, and orphan disease products) to all Israeli public and private hospitals, sick fund clinics, and pharmacies; Tzamal Jakobsohn, the medical equipment division, which imports, markets, sells, and services state-of-the-art medical devices and durable products across cardiology, vascular surgery, interventional procedures, neuro-radiology, general surgery, orthopaedics, neurosurgery, ophthalmology, and capital equipment to all Israeli hospitals and major clinics; and Tzamal D-Chem Laboratories, formed in 2011 through a merger with D-Chem Ltd., which supplies fine chemicals in lab and industrial scale quantities to pharmaceutical, chemical, and microelectronics customers across the production cycle from R&D through mass production.

The group's commercial model is B2B enterprise distribution with a direct field-sales motion, generating revenue through one-time transactional sales of distributed medical devices, pharmaceuticals, and laboratory chemicals rather than recurring subscription or licensing revenue. Pricing is not publicly disclosed and is handled via direct commercial negotiation. Tzamal's value proposition rests on 45+ years of incumbency, exclusive principal relationships with distinguished global medical device and pharmaceutical manufacturers, and a full suite of regulatory credentials including GMP, ISO 9001-2015, ISO 27001-2013, and ISO 27799-2008. The group also operates a family office investment arm that finances and nurtures selected late-stage medical technology start-ups, with documented exits including Pulse Cath, Angioscore, and Hernia Solutions. The company employs approximately 100 professionals and has reported continuous double-digit annual growth, with its entire operating footprint confined to the Israeli market.

Name

Tzamal Medical Group

Legal name

צ. מ. ל. ציוד רפואי בע"מ

Website

https://tzamal-medical.co.il

Company type

Private

Founded year

1972

Operating status

Operating

Headcount range

51–100 employees

Short description

Tzamal Medical Group is a privately held, Israel-based healthcare distribution platform founded in 1972, operating three subsidiaries that distribute pharmaceuticals, medical devices, and laboratory chemicals to all Israeli hospitals, sick funds, clinics, and pharmacies under exclusive principal agreements.

Ownership category

akta.pro rank

Headquarters

HQ city

Petah Tiqva

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Devices Distribution: Import, marketing and selling of state-of-the-art medical devices and durable products including cardiology, vascular surgery, interventional procedures, neuro-radiology, general surgery, orthopedic, spine, neurosurgery, and capital equipment.
2. Pharmaceutical Products Sales: Sourcing, importing, marketing and selling of pharmaceutical products including oncology, haemato-oncology, bone-marrow transplantation, gynecology, cardiology, anti-infective products, and orphan disease treatments to hospitals and healthcare providers.
3. Laboratory Chemicals and Fine Chemicals Supply: Supplying fine chemicals for pharmaceutical, chemical industries, and microelectronics sectors in both lab and industrial scale quantities.
4. Start-up Investment Returns: Through family office investment arm, nurturing and financing selected medical technology start-ups with returns realized through exits including Pulse Cath, Angioscore, and Hernia Solutions.

Go-to-market motion3 records

Distribution channels3 records

Core offering

Tzamal Medical Group is a privately-owned Israeli healthcare distribution company operating through three subsidiaries: Tzamal Bio-Pharma (pharmaceutical products including oncology, cardiology, and orphan disease treatments), Tzamal Jakobsohn (medical devices and durable equipment for cardiology, surgery, orthopaedics, and neurosurgery), and Tzamal D-Chem Laboratories (fine chemicals for pharmaceutical, chemical, and microelectronics sectors). The group imports, markets, distributes, and services medical devices, pharmaceuticals, and laboratory chemicals for hospitals, clinics, sick funds, and pharmacies across Israel.

Product overview

Tzamal Medical Group operates as a unified healthcare distribution platform with three distinct subsidiaries serving the Israeli medical market. Tzamal Bio-Pharma handles ethical and generic pharmaceuticals for hospitals and clinics. Tzamal Jakobsohn (Medical Equipment division) supplies advanced medical devices across cardiology, surgery, orthopaedics, and neurosurgery. Tzamal D-Chem Laboratories provides fine chemicals and laboratory materials for pharmaceutical, chemical, and microelectronics industries. The Group also nurtures and invests in innovative medical device start-ups.

Differentiator

Problem solved

Functional benefit

Products and services

• Tzamal Bio-Pharma Sourcing, importing, marketing, and selling of pharmaceutical products including oncology, haemato-oncology, bone-marrow transplantation, gynecology, cardiology, anti-infective products, and orphan disease treatments. Supplies all public and private hospitals, Sick Funds' healthcare clinics, and pharmacies in Israel.
• Tzamal Jakobsohn (Medical Equipment Division) Import, marketing, and selling of state-of-the-art medical devices and durable products including cardiology/cardiovascular, general and minimal invasive surgery, surgical instruments, ophthalmology, orthopaedics, neurosurgery, and capital equipment. Supplies all hospitals and major healthcare clinics in Israel.
• Tzamal D-Chem Laboratories Specializes in supplying fine chemicals for the Israeli market in both lab and industrial scale quantities, serving pharmaceutical, chemical industries, and microelectronics sectors, providing solutions from R&D through pilot scale to mass production.

Named customers6 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Various Global Medical Device ManufacturerscoreOthersRepresents some of the most distinguished medical device companies in the world for over 45 years, focusing on cardiology, vascular surgery, interventional procedures, neuro-radiology, general surgery, orthopaedics, and neurosurgery.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Medison Pharma: Israeli specialty pharmaceutical distributor partnering with global innovators to bring oncology, rare disease, and specialty therapies to the Israeli market — directly comparable to Tzamal Bio-Pharma's institutional hospital/pharmacy distribution model.
• Henry Schein: Global distributor of medical and dental devices, equipment, and supplies to healthcare providers. Comparable as a multi-product medical device and consumables distributor serving hospitals and clinics worldwide, similar to Tzamal Jakobsohn's offering set.
• Owens & Minor: Distributor of medical and surgical supplies to hospitals and healthcare providers, with a Product-based Healthcare Solutions segment focused on sourcing and supplying medical device manufacturers' products — directly analogous to Tzamal Jakobsohn's hospital-channel medical device distribution.

Broad incumbents

• McKesson: One of the largest pharmaceutical and medical supply distributors globally, with extensive reach into hospitals, pharmacies, and clinics. A broad incumbent operating in the same healthcare distribution space as Tzamal but at vastly larger scale and with international diversification.
• Cencora (formerly AmerisourceBergen): Global pharmaceutical distribution and solutions company supplying pharmacies, hospitals, and healthcare providers. Overlaps with Tzamal's pharmaceutical distribution arm as a broad incumbent serving the same institutional buyer base.
• Cardinal Health: Major US-headquartered healthcare distributor of pharmaceuticals and medical products to hospitals, pharmacies, and clinical settings. Comparable in business model and end-customer overlap to Tzamal's distribution operations.
• Medline Industries: Largest privately-held manufacturer and distributor of medical supplies and clinical solutions, serving hospitals, ambulatory surgery centers, and clinics globally. Comparable in product mix and institutional customer base to Tzamal's device distribution arm.

Emerging players

• Dexcel Pharma: Israeli-headquartered specialty pharmaceutical company with proprietary and licensed products marketed through partnerships and distribution. A regional player in Israeli pharma distribution with partial overlap to Tzamal Bio-Pharma's portfolio.

Others

• Teva Pharmaceutical Industries: Israel-headquartered global pharmaceutical manufacturer. While a manufacturer rather than distributor, Teva operates extensively in the Israeli healthcare ecosystem and is a relevant comparator for understanding the scale and dynamics of Israel's healthcare supply chain.
• Perrigo Company: Global consumer self-care and generic pharmaceutical company with significant Israeli operations and heritage. Relevant comparator as an Israel-based pharma entity, though its manufacturer model differs from Tzamal's pure distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tzamal Medical Group